Curious to see your top suppliers emissions?
Book a demo for a pilot project
Exemed Pharmaceuticals
Medicinal and Botanical ManufacturingIndia
Last verified 4 months agoexemedpharma.com
Exemed Pharmaceuticals, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 2010, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals.
Exemed Pharmaceuticals focuses on therapeutic areas such as oncology, cardiology, and neurology, offering a diverse portfolio of products that are distinguished by their efficacy and safety. The company’s commitment to innovation and quality has earned it a strong market position, with notable achievements in regulatory compliance and product approvals.
With a dedication to improving patient outcomes, Exemed Pharmaceuticals continues to expand its reach and enhance its product offerings, solidifying its reputation as a trusted name in the global pharmaceutical landscape.
15
DitchCarbon score
-9 vs industry average
Exemed Pharmaceuticals’s score of 15 is lower than 19% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Exemed Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Medicinal and Botanical Manufacturing is among the most carbon-intensive industries
Industry performance
0.420
20182025
The Medicinal and Botanical Manufacturing industry has reduced its overall emissions by 28% since 2018
Reported emissions
No reported emissions data is available for Exemed Pharmaceuticals yet.
Exemed Pharmaceuticals's reported carbon emissions
Exemed Pharmaceuticals, headquartered in India, has not reported any specific carbon emissions data for the most recent year. However, the company is committed to significant climate action, aiming for Net Zero emissions by 2045. In January 2024, Exemed's leadership announced a target to reduce carbon emissions by approximately 30% across all scopes by 2045. This commitment reflects a proactive approach to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector.
As of now, there are no specific emissions figures available, but the company's long-term goals align with industry standards for sustainability and climate responsibility. Exemed Pharmaceuticals is dedicated to integrating these climate commitments into its operational strategies, demonstrating a commitment to environmental stewardship.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Exemed Pharmaceuticals’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Exemed Pharmaceuticals4 months ago
15
Frequently asked questions
Common questions about Exemed Pharmaceuticals’s sustainability data and climate commitments
Exemed Pharmaceuticals is committed to achieving Net Zero emissions by approximately 2045. In January 2024, the company announced a target to reduce carbon emissions by around 30% across all scopes by 2045. This proactive approach reflects Exemed's dedication to addressing climate change within the medicinal and botanical manufacturing sector, aligning with industry standards for sustainability and climate responsibility.
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more